Azenta (AZTA) Income from Continuing Operations (2010 - 2026)
Azenta (AZTA) recorded quarterly Income from Continuing Operations of 157021000.0 in Q1 2026, down 2925.45% quarter-over-quarter from 5190000.0 in Q4 2025, and down 693.44% on a YoY basis from 26459631.56 in Q1 2025.
Azenta (AZTA) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Azenta's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 157021000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 693.44% year-over-year to 157021000.0; the TTM figure through Mar 2026 stood at 110890000.0 (down 285.87% YoY), while the FY2025 annual figure was 4361000.0, changed N/A from the prior year.
- Income from Continuing Operations was 157021000.0 for Q1 2026 at Azenta, down from 5190000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 51653000.0 in Q3 2025 to a low of 157021000.0 in Q1 2026.
- Historically, Income from Continuing Operations has averaged 10489764.71 across 5 years, with a median of 5190000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations plunged 741.84% in 2024, then surged 3060.06% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 11275000.0 in 2022, then jumped by 49.18% to 5730000.0 in 2023, then dropped by 23.44% to 7073000.0 in 2024, then grew by 26.62% to 5190000.0 in 2025, then tumbled by 2925.45% to 157021000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 157021000.0 (Q1 2026), 5190000.0 (Q4 2025), and 51653000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn | -157.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157.02 Mn |
| Dec 31, 2025 | -5.19 Mn |
| Sep 30, 2025 | 51.65 Mn |
| Jun 30, 2025 | -332,000.00 |
| Mar 31, 2025 | -19.79 Mn |
| Dec 31, 2024 | -7.07 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -130,000.00 |
| Mar 31, 2024 | -16.76 Mn |
| Dec 31, 2023 | -5.73 Mn |
| Sep 30, 2023 | -25.75 Mn |
| Jun 30, 2023 | -2.47 Mn |
| Mar 31, 2023 | -1.99 Mn |
| Dec 31, 2022 | -11.28 Mn |
| Sep 30, 2022 | 34.08 Mn |
| Jun 30, 2022 | -7.02 Mn |
| Mar 31, 2022 | -1.79 Mn |
| Dec 31, 2021 | 2.86 Mn |
| Sep 30, 2021 | -82.66 Mn |
| Jun 30, 2021 | -1.80 Mn |